AT
Altrartis Therapeutics Inc.
SEC filingOther · New York, NY
Amount raised$11Msold at filing
Total offering$11M
Investors in the raise11count reported to the SEC
FiledOct 22, 2026first sale Aug 12, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Florian BrandExecutive Officer, Director, Promoter
Lars Christian WildeDirector
Executive officers, directors and promoters as listed on the Form D.